HE commonest cause of death following coronary occlusion, certainly in the experimental animal if not in the human being, is ventricular fibrillation. We wish to report the relative effect of chronic ischemia alone and of a myocardial revascularization procedure on the susceptibility of the heart to ventricular fibrillation. Two questions in this regard that might be answered by the measurement of ventricular fibrillation thresholds are: 1. Can we, by operative means, increase the stability of the heart after coronary occlusion over that which might occur in time without operation? 2. Is a return of fibrillation threshold to normal after coronary occlusion necessarily associated with revascularization of the ischemic area?
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Wiggers and co-workers 1 first demonstrated that coronary occlusion caused a decrease in the fibrillation threshold in the area of distribution of the vessel occluded. In our laboratory, in a study of 93 dogs, we have found a decrease from 21 milliamperes (mean) to 4.9 milliamperes (mean) in the fibrillation threshold after occlusion of the anterior descending branch of the left coronary artery.
2 Previous studies 2 have established also that while there is considerable variation of the fibrillation threshold among dogs, this is a very precise determination which remains constant in any given dog. Repeat determinations of the ventricular fibrillation threshold up to 6 times on the same day or on subsequent days have Dr. MacLean is a Markle Scholar in Medical Sciences.
Beceived for publication December 2, 1959. not varied by more than 2.5 milliamperes for any given dog. The temperature of the animal is of great importance when one is occluding the coronary circulation. The fibrillation threshold is lowered by a decline of temperature (even of 1 or 2 C.) and is raised by an elevated temperature. 2 In the present investigation, the temperature of the dogs studied was maintained at between 37.5-38.5 C.
Methods
This investigation was performed on adult, mongrel dogs of either sex, weighing between 9.5 and 21.0 Kg. Following the intravenous administration of sodium pentobarbital 30 mg./Kg., the heart was exposed through a left thoracotomy in the fifth intercostal space. Sterile technic was used for all procedures. All animals were ventilated with compressed room air, using an electronic respirator. The minor alterations in depth of anesthesia that occurred throughout similar experiments have been shown not to alter significantly the fibrillation threshold.
2 Body temperature was measured in the esophagus and was maintained at between 37.5 and 38.5 C, utilizing a Hypo-Hyper Thermia unit.* Previous studies have indicated that esophageal temperature most closely reflects cardiac temperature and is superior to the rectal temperature. The pericardium was incised longitudinally and all thresholds were determined on the left ventricle in the area of distribution of the anterior descending branch of the left coronary artery.
The instrumentation used was similar to that described by Shumway, Johnson and Stish. 3 Amplified electrocardiogram potentials were fed into a triggering" circuit, the output of which was coupled to the synchronizing input of a Grass stimulator.-j-The output of the stimulator was connected to a bipolar electrode. One lead of the electrode contained a 2,500 ohm resistor to minimize the effects of changing resistances between the electrodes and the cardiac surface. Two oscilloscopes were used. On 1, the electrocardiogram was displayed. The stimulator output was applied to this oscilloscope so that brightening of the trace at the moment of stimulation provided a direct method of determining precisely the location of the stimulus in the cardiac cycle. The other oscilloscope was used to determine the magnitude in milliamperes of the current delivered. The trigger circuit provided a single synchronizing pulse for the stimulator upon the occurrence of the first R wave after the trigger button was released. A wide range of stimulus strength, and delay following the R wave were provided by the stimulator. A stimulus duration of 10 milliseconds was used in all tests. In all animals studied, an initial ventricular fibrillation threshold was determined by sweeping the vulnerable period (terminal 30 to 90 milliseconds of systole) of the cardiac cycle w r ith stimuli of increasing current strength from subthreshold to threshold levels. The criterion of threshold was persistent ventricular fibrillation.
The delay setting of the stimulator, which could be varied, was helpful in accurately sweeping the cardiac cycle. The delay period, which determined precisely the location in the cardiac cycle when the stimulus was delivered, was measured from the R wave in the QRS complex. A single stimulus, of 10 milliseconds duration, was delivered to the heart beginning shortly after the QRS complex and was repeated in subsequent cardiac cycles throughout the vulnerable period, and beyond, by progressively increasing the delay in time from the R wave 5 milliseconds after each stimulus. Five to 15 normal beats were allowed to occur between each stimulus.
Since the duration of stimulus was 10 milliseconds, and the delay from the R wave was increased with 5 millisecond increments, we could deliver stimuli to the heart before, during and following the entire vulnerable period. After sweeping the entire vulnerable period at 1 subthreshold strength, the procedure was repeated after increasing the current strength by from 1.0 to 1.5 milliamperes. This was repeated until ventricular fibrillation was produced, at which time the location on the heart surface and the strength of stimulus were recorded. The instrumentation provided a single square wave stimulus of known strength and known duration which could be delivered at a known, measurable and alterable time in the cardiac cycle and which was applied to a known area on the heart surface. After accomplishing fibrillation, the heart was defibrillated quickly, usually in less than 10 seconds, using standard equipment.
The determination of ventricular fibrillation thresholds by the method outlined was made initially and after 5 to 6 months on the following groups of animals: (I) controls (18 dogs); (II) animals in which the left internal mammary artery was implanted into the left ventricle after the method of Vineberg 4 (21 dogs); and (III) animals in which the left anterior descending coronary artery was ligated at the time of the original operation (9 dogs). In one-half of groups I and II, mild ischemia was produced by ligating 1 distal branch of the anterior descending coronary artery and a similar branch of the circumflex artery. Initially, the fibrillation threshold was determined without coronary occlusion and with temporary coronary occlusion in groups I and II and with permanent coronary occlusion in group III. After 5 to 6 months, the animals were reoperated upon and, using the same technic, the fibrillation threshold was redetermined with temporary occlusion of the main left anterior descending coronary artery in groups I and II. In group III, this artery had been permanently occluded 5 to 6 months previously and these animals were • tested without further ligation at this time. In all groups, with or without coronary occlusion, the ventricular fibrillation threshold was determined in the area of distribution of the anterior descending branch of the left coronary artery.
Results
The results appear in tables 1, 2 and 3 and in figure 1. An "analysis of variance" 5 was completed for the treatment groups. This compared the variability among treatment groups with the variability within treatment groups. The effect of chronic mild ischemia, produced by ligating 1 branch of the circumflex and anterior descending coronary arteries, was negligible. The effect of internal mammary artery implantation when this artery remained patent was to prevent the marked drop in the ventricular fibrillation threshold after coronary occlusion. This effect was significant at the 1 per cent level. If the internal mammary artery was demonstrated to be thrombosed, the marked drop in fibrillation threshold after coronary occlusion was not prevented. No significant difference existed between the decline seen in the animals with internal mammary implantation when this vessel had thrombosed and that seen in the control group. The above values were obtained 5 to 6 months fol lowing ligation of 1 brunch of the anterior descending and of the circumflex arteries (with ischemia) or 5 to 6 months following thoracotomy with pericardiotomy (without ischemia).
In 1 animal (No. 1815; table 2b), a small decline in fibrillation threshold occurred following left anterior descending coronary occlusion. When the internal mammary artery was ligated also, the fibrillation threshold dropped to dangerous levels, as seen in the controls. Table 3 illustrates the results of massive ischemia alone (group III). In these dogs, an initial ventricular fibrillation threshold was determined and the main left anterior descending artery was then ligated and the threshold redetermined. After an interval of 5 to 6 months, the ventricular fibrillation threshold was redetermined in the 9 dogs that survived. This is a select group and presumably represents those dogs most resistant to ventricular fibrillation. 
INTERNAL MAMMARY IMPLANT

Figure 1 The ventricular fibrillation threshold ratio after/ before coronary occlusion is illustrated for control dogs and animals with internal mammary artery implantation. There is a marked decline in fibrillation threshold to approximately 30 per cent of normal after coronary occlusion in controls and in animals in which the internal mammary artery thrombosed. If the internal mammary implant remained patent, very little change was noted after coronary occlusion. The thresholds were determined 5 to 6 months after internal mammary implantation or exploration alone (controls). The standard error of the mean is illustrated for each group.
not be defibrillated and died while still on the operating table at the time of initial testing. The mean threshold without occlusion in table 3 was IS.5 milliamperes. After coronary occlusion at that time it fell to 5.7 milliamperes (mean), which corresponds to the results previously reported by us for acute occlusion. After 5 to 6 months, there was some elevation to 8.5 milliamperes (mean). The change appears to be in the direction of improvement over the 5 to 6 month period, but this is not a significant change for this sample size.
Discussion
Many factors, physiologic, physical and chemical, render the heart more susceptible or less vulnerable to ventricular fibrillation. Quantitation of the relative importance of some of these factors has been previously at- tempted by means of inexact bioassay technics, such as the mortality rate following experimental coronary occlusion or measurement of time elapsed between experimental coronary occlusion and onset of ventricular fibrillation.
The replacement of these inexact technics by the use of modern electronic instrumentation combined with threshold measurements, as first suggested 6 and later applied by Wiggers 7 ' 8 affords one the opportunity to measure the degree of change a given factor has induced and do this under controlled conditions. The mode of death in experimental coronary occlusion is predominantly ventricular fibrillation. "Mechanism death" is believed by Beck et al. 9 to be the commonest cause of death in coronary disease in the human being also. Clinicopathologic studies 10 -u support this concept in that many patients die with coronary artery occlusion or narrowing without evidence of myocardial damage. In only a relatively small group, can cardiac death be explained on the basis of destruction of myocardium with associated ventricular rupture or failure. 9 There is evidence that both chronic ischemia and operative procedures designed to revascularize the heart result in a new arterial blood supply of good volume and pressure to the potentially infarcted area. This gives no information as to whether it is sufficient in quantity to nourish the muscle mass previously rendered ischemic. Reduction in mortality or the demonstration of collateral vessels by plastic injection technics does not necessarily signify a significantly improved coronary circulation. To establish the latter it would be necessary to show that blood entering the coronary sinus had actually traversed the capillary bed of the left heart. It is improbable, as Gregg 12 states, that the large backflows from the distal end of a divided artery, obtained experimentally, exist when the chronically occluded coronary artery is not permitted to back-bleed.
In the present study, significant protection from ventricular fibrillation occurred only in the dogs in which the internal mammary artery implant remained open. Thoracotomy with pericardiotomy alone had no effect. Likewise, chronic mild or massive ischemia offered no protection from ventricular fibrillation. Further studies are in progress to determine the minimum collateral flow to a relatively ischemic area of myocardium necessary to restore a normal fibrillation threshold. Additionally, methods are being explored to measure "tissue blood flow" to various portions of the heart to determine what proportion of the collateral blood flow actually reaches the capillary bed and thereby serves in the nutrition and function of the heart. Summary Since ventricular fibrillation is the predominate cause of death following experimental coronary occlusion, measurement of the ventricular fibrillation threshold is recommended to assess the value of cardiac revascularization procedures. This determination is quantitative, precise and permits measurement under controlled circumstances. It was dissatisfaction with measurement of mortality rate following coronary occlusion in control and experimental animals (bioassay technic) that Circulation Research, Volume V1I1, March 1960 led to the adoption of the present more exact method.
Acute ligation of the anterior descending branch of the left coronary artery causes an immediate drop in the fibrillation threshold to one-fifth of normal. This is not changed if one releases the artery and retests the animal with occlusion 5 to 6 months later. Implantation of the internal mammary artery into the myocardium of the left ventricle creates a greater resistance to ventricular fibrillation after coronary occlusion. In animals in which the internal mammary artery remained patent, the fibrillation threshold remained after coronary occlusion at 85 per cent (mean) of control without coronary occlusion. This was highly significant. If the internal mammary artery was thrombosed, as demonstrated by vinyl plastic injection technics, the fibrillation threshold dropped markedly after coronary occlusion and did not vary significantly from the controls. When the anterior descending branch of the left coronary artery was permanently ligated in 1 group of dogs, the expected decline of fibrillation threshold occurred. When the survivals from this group were retested 5 to 6 months later, the fibrillation threshold had increased slightly (not statistically significant) but remained below 50 per cent of control without coronary occlusion and significantly different from the threshold of animals with patent internal mammary artery implants.
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